_id
6911be55ccc777a4e85d62b8
Ticker
GNNSF
Name
Genscript Biotech Corporation
Exchange
PINK
Address
Jiangning Science Park, Nanjing, China, 211100
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.genscript.com
Description
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. The Life Science Services and Products segment provides products and services in various categories, including gene synthesis, oligonucleotide synthesis, peptide synthesis, protein engineering, antibody development, and life-science equipment and consumables, such as molecular diagnostics tools and genome editing materials for biology studies, pharmaceutical and drug discovery, disease diagnostics and vaccine, agriculture, environmental studies, and the food industry. The Biologics Development Services segment which helps biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene/cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment develops and produces industrial enzymes through non-pathogenic microbial strains constructed using genetic engineering. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the People's Republic of China.
Last Close
1.84
Volume
112
Current Price
1.84
Change
0.175
Last Updated
2026-01-03T12:47:58.191Z
Image
data:image/webp;base64,UklGRg4CAABXRUJQVlA4IAICAACQCwCdASpAAEAAPtFepE0oJaOiKBv9+QAaCWQAzd2QD0m7IN5xyKmwQpAcluIFQQz/yVahB+AZSJZCML3h+g3ddexJUinRhoms3aoDX3VWdwJi/5nJVht2axHW7C501Jn2wOJfIAD++E1ghhhP/buIZB3ruWs1eeQ48osYHZuuwtqB8OKZ3JziaExY3QDnt2/EBuCEAxJqlfSQ+eKZZzyc+7jjzLelt2R8Crgcsr5snOwRvsp55y82zmGMPwl3JLmSzIFicyP7ZJuVckm3ybKVhRABeHyJAypZOp2/f/7gxQnkLCKP2BBFpdv6G5fx2urz2/FVtr730ik994ODfpSSEm5uYDTXiUVt6u/l/lsVfZN07ucJKNMLURqzki8sRG+mMSLYmh2d7Z7XcTsxzhP4A/7W8UF9fpadgkV0p9RuJFXYbJdQv5Ii0M1VnFx79Bb1PeVV5/eZsgHEYacSPXN+K5KjPVvObxoWug7NtjMl0FOXJKo7/ANNIa1aRHrrh2TMWYfzp6rXQOuMQy95giN4XEXgnQTn9IXHsCy0zhlyALI9XsRjAiBu8ulZ0617P9xUetfgkB6Wk6Hql/OnRiSBOz/0c8+YZX3SzByOCiAS5xizq0sb4zsjqQKA0yS1j+C6dxgTgjg4JB091JLxLfcjnU9wD5omrkBZNdKljf3xi4AA
Ipo Date
-
Market Cap
4022642176
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
518773000
Cost Of Revenue
198142000
Gross Profit
320631000
Operating Expenses
141537000
Operating Income
179094000
Interest Expense
9132034
Pretax Income
-119000
Net Income
-25462000
Eps
-0.01180942467875241
Dividends Per Share
-
Shares Outstanding
2186218520
Income Tax Expense
24428000
EBITDA
208929000
Operating Margin
34.522613937117
Total Other Income Expense Net
-179213000
Cash
293206000
Short Term Investments
103989000
Receivables
132180000
Inventories
38802000
Total Current Assets
1176806000
Property Plant Equipment
597882000
Total Assets
5434606000
Payables
51728000
Short Term Debt
163820999
Long Term Debt
0
Total Liabilities
1013294000
Equity
4415949000
Bs_currency_symbol
USD
Depreciation
34892000
Change In Working Capital
8897829
Cash From Operations
232619000
Capital Expenditures
32125999
Cash From Investing
-94115929
Cash From Financing
25848957
Net Change In Cash
293206000
Cf_currency_symbol
-
PE
-
PB
0.8983747710854451
ROE
-0.5765918039361414
ROA
-0.46851602489674504
FCF
200493001
Fcf Percent
0.38647539675349335
Piotroski FScore
2
Health Score
53
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
6.8
Garp Investing Score
6
Growth Investing Score
5
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
6
Value Investing Score
5.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
518773000
Quarters > 0 > income Statement > cost Of Revenue
198142000
Quarters > 0 > income Statement > gross Profit
320631000
Quarters > 0 > income Statement > operating Expenses
141537000
Quarters > 0 > income Statement > operating Income
179094000
Quarters > 0 > income Statement > interest Expense
9132034
Quarters > 0 > income Statement > pretax Income
-119000
Quarters > 0 > income Statement > net Income
-25462000
Quarters > 0 > income Statement > eps
-0.01180942467875241
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2156074550
Quarters > 0 > income Statement > income Tax Expense
24428000
Quarters > 0 > income Statement > EBITDA
208929000
Quarters > 0 > income Statement > operating Margin
34.522613937117
Quarters > 0 > income Statement > total Other Income Expense Net
-179213000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
293206000
Quarters > 0 > balance Sheet > short Term Investments
103989000
Quarters > 0 > balance Sheet > receivables
132180000
Quarters > 0 > balance Sheet > inventories
38802000
Quarters > 0 > balance Sheet > total Current Assets
1176806000
Quarters > 0 > balance Sheet > property Plant Equipment
597882000
Quarters > 0 > balance Sheet > total Assets
5434606000
Quarters > 0 > balance Sheet > payables
51728000
Quarters > 0 > balance Sheet > short Term Debt
163820999
Quarters > 0 > balance Sheet > long Term Debt
0
Quarters > 0 > balance Sheet > total Liabilities
1013294000
Quarters > 0 > balance Sheet > equity
4415949000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-25462000
Quarters > 0 > cash Flow > depreciation
34892000
Quarters > 0 > cash Flow > change In Working Capital
8897829
Quarters > 0 > cash Flow > cash From Operations
232619000
Quarters > 0 > cash Flow > capital Expenditures
32125999
Quarters > 0 > cash Flow > cash From Investing
-94115929
Quarters > 0 > cash Flow > cash From Financing
25848957
Quarters > 0 > cash Flow > net Change In Cash
293206000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.01180942467875241
Quarters > 0 > ratios > PB
0.8983747710854451
Quarters > 0 > ratios > ROE
-0.5765918039361414
Quarters > 0 > ratios > ROA
-0.46851602489674504
Quarters > 0 > ratios > FCF
200493001
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.38647539675349335
Quarters > 0 > health Score
53
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
33115000
Quarters > 1 > income Statement > cost Of Revenue
67976000
Quarters > 1 > income Statement > gross Profit
-34861000
Quarters > 1 > income Statement > operating Expenses
-194915000
Quarters > 1 > income Statement > operating Income
173486000
Quarters > 1 > income Statement > interest Expense
20933290
Quarters > 1 > income Statement > pretax Income
34791000
Quarters > 1 > income Statement > net Income
3136992000
Quarters > 1 > income Statement > eps
1.4401090273196036
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
2178301740
Quarters > 1 > income Statement > income Tax Expense
-7066000
Quarters > 1 > income Statement > EBITDA
187973000
Quarters > 1 > income Statement > operating Margin
523.889476068247
Quarters > 1 > income Statement > total Other Income Expense Net
-138695000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
131990000
Quarters > 1 > balance Sheet > short Term Investments
489195000
Quarters > 1 > balance Sheet > receivables
118715000
Quarters > 1 > balance Sheet > inventories
31097000
Quarters > 1 > balance Sheet > total Current Assets
834978000
Quarters > 1 > balance Sheet > property Plant Equipment
602838000
Quarters > 1 > balance Sheet > total Assets
5278269000
Quarters > 1 > balance Sheet > payables
29838000
Quarters > 1 > balance Sheet > short Term Debt
96269000
Quarters > 1 > balance Sheet > long Term Debt
17309000
Quarters > 1 > balance Sheet > total Liabilities
954907000
Quarters > 1 > balance Sheet > equity
4321172000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
3038234382
Quarters > 1 > cash Flow > depreciation
21494385
Quarters > 1 > cash Flow > change In Working Capital
-7740000
Quarters > 1 > cash Flow > cash From Operations
-4208000
Quarters > 1 > cash Flow > capital Expenditures
13894000
Quarters > 1 > cash Flow > cash From Investing
-320053439
Quarters > 1 > cash Flow > cash From Financing
60954000
Quarters > 1 > cash Flow > net Change In Cash
-276778826
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
1.4401090273196036
Quarters > 1 > ratios > PB
0.9275435464267564
Quarters > 1 > ratios > ROE
72.59586056745717
Quarters > 1 > ratios > ROA
59.43221158300192
Quarters > 1 > ratios > FCF
-18102000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.5466404952438472
Quarters > 1 > health Score
73
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
561371000
Quarters > 2 > income Statement > cost Of Revenue
254385000
Quarters > 2 > income Statement > gross Profit
306986000
Quarters > 2 > income Statement > operating Expenses
457758000
Quarters > 2 > income Statement > operating Income
-150772000
Quarters > 2 > income Statement > interest Expense
28965290
Quarters > 2 > income Statement > pretax Income
-205588000
Quarters > 2 > income Statement > net Income
-175115000
Quarters > 2 > income Statement > eps
-0.08273456154136054
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
2116588240
Quarters > 2 > income Statement > income Tax Expense
10043000
Quarters > 2 > income Statement > EBITDA
-117937000
Quarters > 2 > income Statement > operating Margin
-26.85781773550825
Quarters > 2 > income Statement > total Other Income Expense Net
-54816000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
399297000
Quarters > 2 > balance Sheet > short Term Investments
1474638000
Quarters > 2 > balance Sheet > receivables
130812000
Quarters > 2 > balance Sheet > inventories
50835712
Quarters > 2 > balance Sheet > total Current Assets
2214323000
Quarters > 2 > balance Sheet > property Plant Equipment
813715000
Quarters > 2 > balance Sheet > total Assets
3331867000
Quarters > 2 > balance Sheet > payables
59205000
Quarters > 2 > balance Sheet > short Term Debt
45482000
Quarters > 2 > balance Sheet > long Term Debt
305047000
Quarters > 2 > balance Sheet > total Liabilities
1507660000
Quarters > 2 > balance Sheet > equity
1214918000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-175304382
Quarters > 2 > cash Flow > depreciation
40295000
Quarters > 2 > cash Flow > change In Working Capital
93179000
Quarters > 2 > cash Flow > cash From Operations
81981565
Quarters > 2 > cash Flow > capital Expenditures
134026000
Quarters > 2 > cash Flow > cash From Investing
-1136309561
Quarters > 2 > cash Flow > cash From Financing
5181597
Quarters > 2 > cash Flow > net Change In Cash
-1070304728
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.08273456154136054
Quarters > 2 > ratios > PB
3.2055845428251124
Quarters > 2 > ratios > ROE
-14.413729980130347
Quarters > 2 > ratios > ROA
-5.255762009708071
Quarters > 2 > ratios > FCF
-52044435
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.0927095183042943
Quarters > 2 > health Score
21
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
280685500
Quarters > 3 > income Statement > cost Of Revenue
127192500
Quarters > 3 > income Statement > gross Profit
153493000
Quarters > 3 > income Statement > operating Expenses
228879000
Quarters > 3 > income Statement > operating Income
-75386000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-102794000
Quarters > 3 > income Statement > net Income
-87557500
Quarters > 3 > income Statement > eps
-0.04136728077068027
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
2116588240
Quarters > 3 > income Statement > income Tax Expense
5021500
Quarters > 3 > income Statement > EBITDA
-58968500
Quarters > 3 > income Statement > operating Margin
-26.85781773550825
Quarters > 3 > income Statement > total Other Income Expense Net
-27408000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
399297000
Quarters > 3 > balance Sheet > short Term Investments
1328432000
Quarters > 3 > balance Sheet > receivables
130812000
Quarters > 3 > balance Sheet > inventories
50857000
Quarters > 3 > balance Sheet > total Current Assets
2214323000
Quarters > 3 > balance Sheet > property Plant Equipment
813715000
Quarters > 3 > balance Sheet > total Assets
3331867000
Quarters > 3 > balance Sheet > payables
59205000
Quarters > 3 > balance Sheet > short Term Debt
45482000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1507660000
Quarters > 3 > balance Sheet > equity
1214918000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-87557500
Quarters > 3 > cash Flow > depreciation
20147500
Quarters > 3 > cash Flow > change In Working Capital
46589500
Quarters > 3 > cash Flow > cash From Operations
39927500
Quarters > 3 > cash Flow > capital Expenditures
67013000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2782500
Quarters > 3 > cash Flow > net Change In Cash
-523553000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.04136728077068027
Quarters > 3 > ratios > PB
3.2055845428251124
Quarters > 3 > ratios > ROE
-7.206864990065173
Quarters > 3 > ratios > ROA
-2.6278810048540353
Quarters > 3 > ratios > FCF
-27085500
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.09649768156887335
Quarters > 3 > health Score
21
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
594486000
Annuals > 0 > income Statement > cost Of Revenue
322361000
Annuals > 0 > income Statement > gross Profit
272125000
Annuals > 0 > income Statement > operating Expenses
262843000
Annuals > 0 > income Statement > operating Income
9282000
Annuals > 0 > income Statement > interest Expense
8032000
Annuals > 0 > income Statement > pretax Income
-170797000
Annuals > 0 > income Statement > net Income
2961877000
Annuals > 0 > income Statement > eps
1.3597184199099983
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
2178301740
Annuals > 0 > income Statement > income Tax Expense
2977000
Annuals > 0 > income Statement > EBITDA
70036000
Annuals > 0 > income Statement > operating Margin
1.5613487954300016
Annuals > 0 > income Statement > total Other Income Expense Net
-180079000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
131990000
Annuals > 0 > balance Sheet > short Term Investments
489195000
Annuals > 0 > balance Sheet > receivables
118715000
Annuals > 0 > balance Sheet > inventories
31083933
Annuals > 0 > balance Sheet > total Current Assets
834978000
Annuals > 0 > balance Sheet > property Plant Equipment
602584691
Annuals > 0 > balance Sheet > total Assets
5278269000
Annuals > 0 > balance Sheet > payables
29838000
Annuals > 0 > balance Sheet > short Term Debt
96269000
Annuals > 0 > balance Sheet > long Term Debt
17309000
Annuals > 0 > balance Sheet > total Liabilities
954907000
Annuals > 0 > balance Sheet > equity
4321172000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
2862930000
Annuals > 0 > cash Flow > depreciation
61789385
Annuals > 0 > cash Flow > change In Working Capital
85439000
Annuals > 0 > cash Flow > cash From Operations
75647000
Annuals > 0 > cash Flow > capital Expenditures
147920000
Annuals > 0 > cash Flow > cash From Investing
-1456363000
Annuals > 0 > cash Flow > cash From Financing
66519000
Annuals > 0 > cash Flow > net Change In Cash
-1314413000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
1.3597184199099983
Annuals > 0 > ratios > PB
0.9275435464267564
Annuals > 0 > ratios > ROE
68.54337202962529
Annuals > 0 > ratios > ROA
56.11455194875441
Annuals > 0 > ratios > FCF
-72273000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
-0.12157224896801606
Annuals > 0 > health Score
75
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
839529000
Annuals > 1 > income Statement > cost Of Revenue
429976000
Annuals > 1 > income Statement > gross Profit
409553000
Annuals > 1 > income Statement > operating Expenses
825344000
Annuals > 1 > income Statement > operating Income
-415791000
Annuals > 1 > income Statement > interest Expense
27510000
Annuals > 1 > income Statement > pretax Income
-350979000
Annuals > 1 > income Statement > net Income
-95477000
Annuals > 1 > income Statement > eps
-0.04526337793548078
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2109365327
Annuals > 1 > income Statement > income Tax Expense
4142000
Annuals > 1 > income Statement > EBITDA
-248719520
Annuals > 1 > income Statement > operating Margin
-49.526698899025526
Annuals > 1 > income Statement > total Other Income Expense Net
142691000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1446403000
Annuals > 1 > balance Sheet > short Term Investments
481647000
Annuals > 1 > balance Sheet > receivables
299661666
Annuals > 1 > balance Sheet > inventories
53346000
Annuals > 1 > balance Sheet > total Current Assets
2353111000
Annuals > 1 > balance Sheet > property Plant Equipment
750741235
Annuals > 1 > balance Sheet > total Assets
3387302000
Annuals > 1 > balance Sheet > payables
39959000
Annuals > 1 > balance Sheet > short Term Debt
65878000
Annuals > 1 > balance Sheet > long Term Debt
287207000
Annuals > 1 > balance Sheet > total Liabilities
1342948000
Annuals > 1 > balance Sheet > equity
1391079000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-350979000
Annuals > 1 > cash Flow > depreciation
74046000
Annuals > 1 > cash Flow > change In Working Capital
-150652000
Annuals > 1 > cash Flow > cash From Operations
-286911000
Annuals > 1 > cash Flow > capital Expenditures
157713000
Annuals > 1 > cash Flow > cash From Investing
-357728000
Annuals > 1 > cash Flow > cash From Financing
1068260000
Annuals > 1 > cash Flow > net Change In Cash
422404000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.04526337793548078
Annuals > 1 > ratios > PB
2.79008755195068
Annuals > 1 > ratios > ROE
-6.863521050925217
Annuals > 1 > ratios > ROA
-2.8186739771062634
Annuals > 1 > ratios > FCF
-444624000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.5296112463059645
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
625698000
Annuals > 2 > income Statement > cost Of Revenue
321615000
Annuals > 2 > income Statement > gross Profit
304083000
Annuals > 2 > income Statement > operating Expenses
742059000
Annuals > 2 > income Statement > operating Income
-436038000
Annuals > 2 > income Statement > interest Expense
13269000
Annuals > 2 > income Statement > pretax Income
-431690000
Annuals > 2 > income Statement > net Income
-226851000
Annuals > 2 > income Statement > eps
-0.10817187851595798
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
2097134700
Annuals > 2 > income Statement > income Tax Expense
-3719000
Annuals > 2 > income Statement > EBITDA
-355079405
Annuals > 2 > income Statement > operating Margin
-69.68825215998773
Annuals > 2 > income Statement > total Other Income Expense Net
-3934000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1023999000
Annuals > 2 > balance Sheet > short Term Investments
439330000
Annuals > 2 > balance Sheet > receivables
171673358
Annuals > 2 > balance Sheet > inventories
59935000
Annuals > 2 > balance Sheet > total Current Assets
1764950000
Annuals > 2 > balance Sheet > property Plant Equipment
646923000
Annuals > 2 > balance Sheet > total Assets
2546383000
Annuals > 2 > balance Sheet > payables
55755000
Annuals > 2 > balance Sheet > short Term Debt
44785000
Annuals > 2 > balance Sheet > long Term Debt
261006000
Annuals > 2 > balance Sheet > total Liabilities
1183715000
Annuals > 2 > balance Sheet > equity
1010541000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-431690000
Annuals > 2 > cash Flow > depreciation
64248000
Annuals > 2 > cash Flow > change In Working Capital
169755000
Annuals > 2 > cash Flow > cash From Operations
-120292000
Annuals > 2 > cash Flow > capital Expenditures
203572000
Annuals > 2 > cash Flow > cash From Investing
-443296000
Annuals > 2 > cash Flow > cash From Financing
419317000
Annuals > 2 > cash Flow > net Change In Cash
-156972000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.10817187851595798
Annuals > 2 > ratios > PB
3.81847727900204
Annuals > 2 > ratios > ROE
-22.448470670660566
Annuals > 2 > ratios > ROA
-8.908754103369368
Annuals > 2 > ratios > FCF
-323864000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.5176043394736758
Annuals > 2 > health Score
19
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
511062000
Annuals > 3 > income Statement > cost Of Revenue
207578000
Annuals > 3 > income Statement > gross Profit
282518000
Annuals > 3 > income Statement > operating Expenses
651730000
Annuals > 3 > income Statement > operating Income
-368313590
Annuals > 3 > income Statement > interest Expense
2378000
Annuals > 3 > income Statement > pretax Income
-517363000
Annuals > 3 > income Statement > net Income
-358712000
Annuals > 3 > income Statement > eps
-0.17665341656550848
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
2030597579
Annuals > 3 > income Statement > income Tax Expense
964000
Annuals > 3 > income Statement > EBITDA
-465782948
Annuals > 3 > income Statement > operating Margin
-72.06827938684543
Annuals > 3 > income Statement > total Other Income Expense Net
-149049410
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1180971000
Annuals > 3 > balance Sheet > short Term Investments
222233000
Annuals > 3 > balance Sheet > receivables
169036580
Annuals > 3 > balance Sheet > inventories
44358000
Annuals > 3 > balance Sheet > total Current Assets
1637962000
Annuals > 3 > balance Sheet > property Plant Equipment
492438000
Annuals > 3 > balance Sheet > total Assets
2232770000
Annuals > 3 > balance Sheet > payables
30176000
Annuals > 3 > balance Sheet > short Term Debt
8031000
Annuals > 3 > balance Sheet > long Term Debt
121070000
Annuals > 3 > balance Sheet > total Liabilities
1139815000
Annuals > 3 > balance Sheet > equity
1045992000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-496375000
Annuals > 3 > cash Flow > depreciation
47779000
Annuals > 3 > cash Flow > change In Working Capital
121679000
Annuals > 3 > cash Flow > cash From Operations
-136790000
Annuals > 3 > cash Flow > capital Expenditures
137397000
Annuals > 3 > cash Flow > cash From Investing
-212548000
Annuals > 3 > cash Flow > cash From Financing
902141000
Annuals > 3 > cash Flow > net Change In Cash
551913000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.17665341656550848
Annuals > 3 > ratios > PB
3.5720154125079353
Annuals > 3 > ratios > ROE
-34.29395253500983
Annuals > 3 > ratios > ROA
-16.065783757395522
Annuals > 3 > ratios > FCF
-274187000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.5365043771597184
Annuals > 3 > health Score
19
Valuation > metrics > PE
-0.01180942467875241
Valuation > metrics > PB
0.8983747710854451
Valuation > final Score
70
Valuation > verdict
10.2% Undervalued
Profitability > metrics > ROE
-0.5765918039361414
Profitability > metrics > ROA
-2.163653142489076
Profitability > metrics > Net Margin
-0.049081197363779534
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.22946234206962082
Risk > metrics > Interest Coverage
19.61162212054839
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
5.459575342309987
Liquidity > metrics > Quick Ratio
5.279560588448847
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
47.944154571748875
Prev Valuations > 2
47.944154571748875
Prev Profitabilities > 0
100
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
93
Prev Risks > 1
9
Prev Risks > 2
23
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:55:12.154Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-12
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0231
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0231
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0231
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.0231
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-09-30
Earnings History > 3 > report Date
2020-12-31
Earnings History > 3 > date
2020-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0239
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.0239
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-09-30
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0239
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.0239
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-06-30
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.03
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.03
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2020-03-31
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0301
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.0301
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-12-31
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0187
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.0187
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-09-30
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0187
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0187
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-06-30
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0074
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0074
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0074
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0074
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-31
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.0015
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.0015
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.0015
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.0015
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-06-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.0043
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0.0043
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.0043
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0.0043
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-09-30
Earnings History > 15 > report Date
2017-12-31
Earnings History > 15 > date
2017-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.0032
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0.0032
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-06-30
Earnings History > 16 > report Date
2017-09-30
Earnings History > 16 > date
2017-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.0032
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0.0032
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-03-31
Earnings History > 17 > report Date
2017-06-30
Earnings History > 17 > date
2017-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.0043
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0.0043
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-12-31
Earnings History > 18 > report Date
2017-03-31
Earnings History > 18 > date
2016-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0.0043
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0.0043
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-09-30
Earnings History > 19 > report Date
2016-12-31
Earnings History > 19 > date
2016-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.0038
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0.0038
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-06-30
Earnings History > 20 > report Date
2016-09-30
Earnings History > 20 > date
2016-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0.0038
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0.0038
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2016-03-31
Earnings History > 21 > report Date
2016-06-30
Earnings History > 21 > date
2016-03-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0.0039
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0.0039
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2015-12-31
Earnings History > 22 > report Date
2016-03-31
Earnings History > 22 > date
2015-12-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
0.0039
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0.0039
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2015-09-30
Earnings History > 23 > report Date
2015-12-31
Earnings History > 23 > date
2015-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
0.0048
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0.0048
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2015-06-30
Earnings History > 24 > report Date
2015-09-30
Earnings History > 24 > date
2015-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
0.0048
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
0.0048
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2015-03-31
Earnings History > 25 > report Date
2015-06-30
Earnings History > 25 > date
2015-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
0.0024
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
0.0024
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2014-12-31
Earnings History > 26 > report Date
2015-03-31
Earnings History > 26 > date
2014-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
0.0024
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
0.0024
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2014-09-30
Earnings History > 27 > report Date
2014-12-31
Earnings History > 27 > date
2014-09-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
0.0009
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
0.0009
Earnings History > 27 > surprise Percent
-
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. The Life Science Services and Products segment provides products and services in various categories, including gene synthesis, oligonucleotide synthesis, peptide synthesis, protein engineering, antibody development, and life-science equipment and consumables, such as molecular diagnostics tools and genome editing materials for biology studies, pharmaceutical and drug discovery, disease diagnostics and vaccine, agriculture, environmental studies, and the food industry. The Biologics Development Services segment which helps biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene/cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment develops and produces industrial enzymes through non-pathogenic microbial strains constructed using genetic engineering. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the People's Republic of China.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATech Voices: DOD's Chinese military firm list, Cerebras eyes Q2 IPO Seeking Alpha
Read more →(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Genscript Biotech Corporation
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2021-03-31
EPS Actual
-0.0231
EPS Estimate
0
EPS Difference
-0.0231
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.